U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) scientists, working as part of an international consortium, have developed and tested an antibody-based therapy to treat Crimean-Congo hemorrhagic...
An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study from National Institutes of Health...